These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Altered secretion of type III procollagen in a form of type IV Ehlers-Danlos syndrome. Biochemical studies in cultured fibroblasts. Byers PH; Holbrook KA; Barsh GS; Smith LT; Bornstein P Lab Invest; 1981 Apr; 44(4):336-41. PubMed ID: 6259441 [TBL] [Abstract][Full Text] [Related]
3. Abnormal formation of collagen cross-links in skin fibroblasts cultured from patients with Ehlers-Danlos syndrome type VI. Pasquali M; Still MJ; Vales T; Rosen RI; Evinger JD; Dembure PP; Longo N; Elsas LJ Proc Assoc Am Physicians; 1997 Jan; 109(1):33-41. PubMed ID: 9010914 [TBL] [Abstract][Full Text] [Related]
4. [Ehlers-Danlos syndrome type I. Ultrastructural study]. Paradisi M; Giubilei L; Canzona F; Angelo C; Onetti Muda A; Puddu P Minerva Pediatr; 1997 May; 49(5):215-9. PubMed ID: 9340484 [TBL] [Abstract][Full Text] [Related]
5. Another mechanism for the defect in type III collagen accumulation in Ehlers-Danlos syndrome type IV: increased intracellular degradation of the procollagen. Utani A; Tanaka T; Nishigori C; Miyachi Y; Danno K; Imamura S; Hosokawa M; Takeda T; Hirayoshi K; Nagata K Lab Invest; 1990 Aug; 63(2):181-8. PubMed ID: 2199725 [TBL] [Abstract][Full Text] [Related]
6. [Various characteristics of the structure and synthesis of procollagens produced by cultured skin fibroblasts from patients with Danlos-Ehlers syndrome type I]. Sokolov BP; Sher BM; Lomova TIu; Kukharenko VI; Blinnikova OE Mol Gen Mikrobiol Virusol; 1987 Jan; (1):19-23. PubMed ID: 3561422 [TBL] [Abstract][Full Text] [Related]
7. Ehlers-Danlos syndrome IV due to a novel defect in type III procollagen. Pyeritz RE; Stolle CA; Parfrey NA; Myers JC Am J Med Genet; 1984 Nov; 19(3):607-22. PubMed ID: 6507506 [TBL] [Abstract][Full Text] [Related]
9. Pathomorphological and biochemical alterations in Ehlers-Danlos-syndrome type IV. Nerlich AG; Stöss H; Lehmann H; Krieg T; Müller PK Pathol Res Pract; 1994 Aug; 190(7):697-706; discussion 706-7. PubMed ID: 7808968 [TBL] [Abstract][Full Text] [Related]
10. Periodontal Ehlers-Danlos syndrome associated with type III and I collagen deficiencies. Mataix J; Bañuls J; Muñoz C; Bermejo A; Climent JM Br J Dermatol; 2008 Apr; 158(4):825-30. PubMed ID: 18284404 [TBL] [Abstract][Full Text] [Related]
11. Tenascin-X deficiency mimics Ehlers-Danlos syndrome in mice through alteration of collagen deposition. Mao JR; Taylor G; Dean WB; Wagner DR; Afzal V; Lotz JC; Rubin EM; Bristow J Nat Genet; 2002 Apr; 30(4):421-5. PubMed ID: 11925569 [TBL] [Abstract][Full Text] [Related]
12. [Synthesis of procollagen proteins in cultured skin fibroblasts of patients with Ehlers-Danlos type I syndrome from a subisolated Azerbaijan population]. Lomova TIu; Sher BM; Shakhova IK; Del'vig AA; Kukharenko VI Mol Gen Mikrobiol Virusol; 1986 Feb; (2):35-9. PubMed ID: 2946946 [No Abstract] [Full Text] [Related]
13. Diagnosis of vascular Ehlers-Danlos syndrome in Italy: clinical findings and novel COL3A1 mutations. Drera B; Zoppi N; Ritelli M; Tadini G; Venturini M; Wischmeijer A; Nicolazzi MA; Musumeci A; Penco S; Buscemi L; Crivelli S; Danesino C; Clementi M; Calzavara-Pinton P; Viglio S; Valli M; Barlati S; Colombi M J Dermatol Sci; 2011 Dec; 64(3):237-40. PubMed ID: 22019127 [No Abstract] [Full Text] [Related]
14. [Collagen type I, III, IV and V and fibronectin in skin biopsies of patients with Ehlers-Danlos syndrome and cutis laxa]. Shekhonin BV; Semiachkina AN; Makkaev KhM; Domogatskiĭ SP; Idel'son GL Arkh Patol; 1988; 50(12):41-8. PubMed ID: 3074749 [TBL] [Abstract][Full Text] [Related]
15. Collagen biosynthesis and isomorphism in a case of Ehlers-Danlos syndrome type VI. Chamson A; Berbis P; Fabre JF; Privat Y; Frey J Arch Dermatol Res; 1987; 279(5):303-7. PubMed ID: 3115194 [TBL] [Abstract][Full Text] [Related]
16. [Biochemical defects in hereditary diseases of the connective tissue (review)]. Del'vig AA Vopr Med Khim; 1986; 32(2):2-14. PubMed ID: 3518233 [No Abstract] [Full Text] [Related]
17. [Type IV Ehlers-Danlos syndrome of acrogeria type]. Boullie MC; Venencie PY; Thomine E; Ogier H; Puissant A; Lauret P Ann Dermatol Venereol; 1986; 113(11):1077-85. PubMed ID: 3813397 [TBL] [Abstract][Full Text] [Related]
18. Low levels of serum type III procollagen aminoterminal propeptide confirmed type III collagen deficiency in patients without typical clinical symptoms of Ehlers-Danlos type IV. Dyne KM; Zanaboni G; Annoni G; De Agostini MP; Cetta G Eur J Clin Invest; 1989 Aug; 19(4):362-6. PubMed ID: 2506053 [TBL] [Abstract][Full Text] [Related]
19. Ehlers-Danlos syndrome type IV: a subset of patients distinguished by low serum levels of the amino-terminal propeptide of type III procollagen. Steinmann B; Superti-Furga A; Joller-Jemelka HI; Cetta G; Byers PH Am J Med Genet; 1989 Sep; 34(1):68-71. PubMed ID: 2816989 [TBL] [Abstract][Full Text] [Related]
20. Aberrant splicing of the type III procollagen mRNA leads to intracellular degradation of the protein in a patient with Ehlers-Danlos type IV. Thakker-Varia S; Anderson DW; Kuivaniemi H; Tromp G; Shin HG; van der Rest M; Glorieux FH; Ala-Kokko L; Stolle CA Hum Mutat; 1995; 6(2):116-25. PubMed ID: 7581395 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]